Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apimeds Pharmaceuticals Us, Inc. (APUS) since 2025 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Apimeds Pharmaceuticals Us, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1894525.
Total stock buying since 2025: $2,107,073.
Total stock sales since 2025: $0.
Total stock option exercises since 2025: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 556,000 | $2,107,073 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 556,000 | $2,107,073 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-14 | Kim Christopher (Chairman and CMO) | Buy | 7,730 | 1.86 | 14,377 |
| 2025-05-13 | Kim Christopher (Chairman and CMO) | Buy | 19,770 | 1.82 | 35,981 |
| 2025-05-12 | Inscobee Inc. (10% Owner) | Buy | 500,000 | 4.00 | 2,000,000 |
| 2025-05-12 | Koo Jakap (Director) | Buy | 28,500 | 1.99 | 56,715 |
Insider trading activities including stock purchases, stock sales, and option exercises of APUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Apimeds Pharmaceuticals Us, Inc. (symbol APUS, CIK number 1894525) see the Securities and Exchange Commission (SEC) website.